Show simple item record

Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID‐19

dc.contributor.authorWhyte, Claire S.
dc.contributor.authorMorrow, Gael B.
dc.contributor.authorMitchell, Joanne L.
dc.contributor.authorChowdary, Pratima
dc.contributor.authorMutch, Nicola J.
dc.date.accessioned2020-07-06T06:45:03Z
dc.date.available2020-07-06T06:45:03Z
dc.date.issued2020-07
dc.identifier.citationWhyte , C S , Morrow , G B , Mitchell , J L , Chowdary , P & Mutch , N J 2020 , ' Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID‐19 ' , Journal of Thrombosis and Haemostasis , vol. 18 , no. 7 , pp. 1548-1555 . https://doi.org/10.1111/jth.14872en
dc.identifier.issn1538-7933
dc.identifier.otherPURE: 161952080
dc.identifier.otherPURE UUID: c189dc04-8aee-4e1b-bb87-f90c7734e2e8
dc.identifier.otherScopus: 85084616473
dc.identifier.otherPubMed: 32329246
dc.identifier.otherPubMedCentral: PMC7264738
dc.identifier.otherWOS: 000537272200001
dc.identifier.otherPubMed: 32329246
dc.identifier.otherORCID: /0000-0001-8127-6102/work/101050691
dc.identifier.otherORCID: /0000-0001-9299-6754/work/116417845
dc.identifier.urihttps://hdl.handle.net/2164/14655
dc.descriptionOpen Access via the Wiley Jisc Agreement With thanks to Wai-Lum Sum from Medical Illustration at the University of Aberdeen with help in compiling figure 2 of the manuscript. British Heart Foundation (GrantNumber(s): FS/11/2/28579, PG/15/82/31721)en
dc.format.extent8
dc.language.isoeng
dc.relation.ispartofJournal of Thrombosis and Haemostasisen
dc.rights© 2020 The Authors. Journal of Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. https://creativecommons.org/licenses/by/4.0/en
dc.subjectFibrinolysisen
dc.subjectFibrinen
dc.subjectPlasminogen Activator Inhibitor 1en
dc.subjectTissue plasminogen activatoren
dc.subjectRespiratory distress syndrome (Adult)en
dc.subjectSARS virusen
dc.subjectFACTOR XAen
dc.subjecttissue plasminogen activatoren
dc.subjectMACROPHAGEen
dc.subjectACUTE LUNG INJURYen
dc.subjectPLASMINOGEN-ACTIVATOR INHIBITOR-1en
dc.subjectrespiratory distress syndrome (adult)en
dc.subjectPNEUMONIAen
dc.subjectplasminogen activator inhibitor 1en
dc.subjectINTERLEUKIN-8en
dc.subjectfibrinolysisen
dc.subjectELEVATED LEVELSen
dc.subjectCOAGULATIONen
dc.subjectfibrinen
dc.subjectEXPRESSIONen
dc.subjectTISSUE FACTORen
dc.subjectR Medicine (General)en
dc.subjectHematologyen
dc.subjectBritish Heart Foundationen
dc.subjectFS/11/2/28579en
dc.subjectPG/15/82/31721en
dc.subject.lccR1en
dc.titleFibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID‐19en
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Applied Medicineen
dc.contributor.institutionUniversity of Aberdeen.Institute of Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciences - Cardiovascular Groupen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1111/jth.14872
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85084616473&partnerID=8YFLogxKen
dc.identifier.vol18en
dc.identifier.iss7en


Files in this item

Thumbnail
Name:
Whyte_etal_jth_Fibrinolytic_ab ...
Size:
802.0Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record